Biotechnology News

August 3, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from a new Premier agreement for anti-infection site disc dressings

August 3, 2012

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced the pricing of its initial public offering of 8,333,333 shares of Class A common stock at a price of $12 per share, consisting...

August 3, 2012

JACKSON CENTER, Pa.--(BUSINESS WIRE)--Premier Biomedical, Inc. (OTCBB: BIEI) announced that they have begun trading on the OTC-BB fully reporting index at “BIEI”. Premier Biomedical Inc’s principal technology is based on the Felder Doctrine™, “To...

August 3, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the 32nd Annual Canaccord Genuity Growth Conference on Wednesday, August 15 at 10:30 a.m. (ET) in Boston. The presentation will be webcast live...

August 3, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today reported financial results for...

August 3, 2012

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) today announced its acquisition of Farmadiet Group Holding, S.L., a Barcelona-based company currently engaged in the development, manufacture, marketing, and sale of pharmaceutical,...

August 3, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: iPads, iPhones and Other Mobile Devices Inspire New Biotech Applications

August 3, 2012

OSLO, Norway--(BUSINESS WIRE)--DiaGenic has received notice of allowance of the family 3 patent application in Japan ( 2007-514130). The claims allowed cover the use of some important gene sequences in blood sample for detection and monitoring of...

August 2, 2012

WASHINGTON--(BUSINESS WIRE)--Sen. Debbie Stabenow of Michigan today introduced legislation for a production tax credit for renewable chemicals, which use U.S. biotechnology and agriculture and can revitalize U.S. manufacturing.

August 2, 2012

OTAWARA, Japan--(BUSINESS WIRE)--Toshiba Medical Systems Corporation has established the Chinese Procurement Center in Shanghai. Our procurement bases were previously at our headquarters and in Dalian, China. By opening the Chinese Procurement...

August 2, 2012

WASHINGTON--(BUSINESS WIRE)--A coalition of stakeholder organizations thank the Senate Finance Committee for including Defense Production Act funding in the 2013 Defense Appropriations Bill.

August 2, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) today thanked Sens. Max Baucus (D-Mont.) and Orrin Hatch (R-Utah) and members of the Senate Finance Committee for including the Cellulosic Biofuels Producer Tax Credit (...

August 2, 2012

NEWARK, Del.--(BUSINESS WIRE)--SDIX (Nasdaq: SDIX) - a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic, and food safety applications, expects to release its second quarter...

August 2, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today reported financial results for the quarter ended June 30, 2012. During the quarter, Exelixis continued its progress in advancing cabozantinib towards...

August 2, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex today reported its financial and operating results for the quarter ended June 30, 2012.

August 2, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex announced today it has restructured its Loan and Security Agreement with MidCap Financial LLC and Silicon Valley Bank to add $30.0 million in capital to the existing $10.0 million loan

August 2, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Technology Growth Capital, Inc. (NYSE:HTGC), the leading specialty finance company focused on providing senior secured loans to entrepreneurial venture capital and private equity-backed companies in...

August 2, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the second quarter ended July 1, 2012. The Company...

August 2, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus reports Q2-12 financial results; company will host a conference call and webcast at 4:15 p.m. Eastern time today to discuss its results and provide a general business overview.

August 2, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today its financial results for the second quarter and six months ended June 30, 2012. Total revenues for Q2 and the first six months of 2012 were $70.4 million and...

August 2, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. Reports Second Quarter 2012 Earnings Results

August 2, 2012

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its second quarter ended June...

August 2, 2012

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Wi names industry veterans in medical device industry to its newly formed Board of Advisors.

August 2, 2012

MILWAUKEE--(BUSINESS WIRE)--CEO Cynthia (Dohmen) LaConte announced today that the Dohmen Company has acquired Reglera, a leading provider of regulatory affairs services to medical device and tissues industries.

August 2, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Suppliers being accepted to showcase advances in healthcare at national event

August 2, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces $5.36 Million Registered Direct Financing - proceeds for general corporate purposes including funding clinical trials for poster uveitis and other business operations

August 2, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics schedules Second quarter 2012 financial results and conference call for August 7, 2012.

August 2, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced treatment of the fourth patient, the first in the second patient cohort, in the company’s...

August 2, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SciFluor Life Sciences, a drug discovery and development company harnessing the transformational power of fluorine to accelerate the development of innovative new therapeutics, today announced that the company’s...

August 2, 2012

NEW YORK--(BUSINESS WIRE)--European-based contract research organization (CRO) TFS has implemented Medidata CTMS™, a leading software-as-a-service (SaaS) clinical trial management system offered by Medidata Solutions.

August 2, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD), together with Mylan Laboratories, Ranbaxy Laboratories Limited and Strides Arcolab, announced today that they have entered into agreements to collaborate on promoting...

August 2, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (NASDAQ: CLDX) will release second quarter 2012 financial results on Friday, August 10, 2012 before the U.S. financial markets open. Celldex executives will host a conference call at 8:...

August 2, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science Inc. (OTCBB:CBIS) announced today the presentation on the effects of phytocannabinoid inhibition on HIV TAT at the World AIDS Institute Treatment Horizons Satellite Symposium during AIDS...

August 2, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company, today reported financial results for the quarter ended June 30, 2012 and highlighted recent corporate progress.

August 2, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--OXBT and the Navy have had a long relationship conducting research using the company's lead product candidate Oxycyte for conditions such as the bends, hemorrhagic shock, TBI, and potentially wounds.

August 2, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the second quarter and six months ended June 30, 2012 and provided an update on corporate developments. “The second quarter of 2012...

August 2, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix launches RNA amplification reagent kit to enable expression biomarker discovery and validation from FFPE samples

August 2, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Announces Strategic Realignment and Q2 Earnings Results

August 2, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today reported financial results for the quarter ended June 30, 2012 and provided clinical program updates. “We continue to make strong progress in advancing our...

August 2, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta (NASDAQ: SNTA) announced that the first patients have been treated in two trials evaluating ganetespib, an Hsp90 inhibitor in ALK+ NSCLC.

August 2, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today reported results for the quarter ended June 30, 2012. Highlights: Net revenues of $5.0 billion, compared to $4.2 billion in the second quarter of 2011, an increase...

August 2, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals reports publication in the Journal of Clinical Oncology of positive Phase 2 clinical data for ZEVALIN® (ibritumomab tiuxetan) Injection in patients with mantel-cell lymphoma.

August 2, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that it will release its unaudited financial results for the three-months ended June 30, 2012 on Wednesday, August 15...

August 2, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today reports second quarter 2012 financial results and...

August 2, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule reports second quarter 2012 results.

August 2, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today reported second-quarter 2012 financial results, including revenue from its first commercial product, Jakafi® (ruxolitinib), which was approved by the US Food & Drug...

August 2, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the second quarter and six months ended June 30, 2012. “Following the completion of the preclinical safety studies...

August 2, 2012

BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: DBV Technologies (Euronext: DBV – ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergy, announced today that the first patient has been enrolled, on July 31st, in...